BKR:NASDAQBaker Hughes Company Analysis
Data as of 2026-03-10 - not real-time
$60.10
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Baker Hughes is trading at $60.10, comfortably above its 50‑day SMA ($55.97) and 200‑day SMA ($47.27) but just shy of the 20‑day SMA ($62.02), signaling a short‑term pull‑back within a longer‑term uptrend. The RSI sits at 49.6, indicating neutral momentum, while the MACD histogram remains negative, suggesting lingering bearish pressure. Volume is rising and the price is anchored above the identified support of $58.43, with upside potential toward the $67 resistance level. The Fear & Greed Index at 75.9 (“Extreme Greed”) reflects strong market optimism, yet the 30‑day volatility of over 30% and a beta near 1.1 highlight notable price swings.
Fundamentally, BKR posts modest revenue growth (0.3%), solid ROE (14.5%), and a healthy dividend yield (1.53%) backed by a 35% payout ratio, indicating dividend sustainability. The forward P/E of 20.66 is above the industry average of 20.57, suggesting slight overvaluation, while the DCF fair value aligns closely with the current price, resulting in a neutral upside/downside estimate of ~2%. Recent material news includes a quarterly dividend declaration and the successful pricing of a $6.5 billion debt offering, reinforcing cash flow discipline but also adding leverage to an already high debt‑to‑equity profile.
Fundamentally, BKR posts modest revenue growth (0.3%), solid ROE (14.5%), and a healthy dividend yield (1.53%) backed by a 35% payout ratio, indicating dividend sustainability. The forward P/E of 20.66 is above the industry average of 20.57, suggesting slight overvaluation, while the DCF fair value aligns closely with the current price, resulting in a neutral upside/downside estimate of ~2%. Recent material news includes a quarterly dividend declaration and the successful pricing of a $6.5 billion debt offering, reinforcing cash flow discipline but also adding leverage to an already high debt‑to‑equity profile.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near established support at $58.43
- Increasing volume supporting a potential bounce
- MACD bearish divergence cautioning against a quick rally
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Bullish alignment above 50‑day and 200‑day SMAs
- Sustainable dividend yield and solid cash flow generation
- Potential upside to resistance near $67
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Energy transition and cyclical oilfield services exposure
- Elevated leverage from recent $6.5 billion debt issuance
- Consistent dividend policy and respectable ROE
Key Metrics & Analysis
Financial Health
Revenue Growth0.30%
Profit Margin9.33%
P/E Ratio23.1
ROE14.55%
ROA5.54%
Debt/Equity35.26
P/B Ratio3.1
Op. Cash Flow$3.8B
Free Cash Flow$1.1B
Industry P/E20.6
Technical Analysis
TrendBullish
RSI49.6
Support$58.43
Resistance$67.00
MA 20$62.02
MA 50$55.97
MA 200$47.27
MACDBearish
VolumeIncreasing
Fear & Greed Index75.89
Valuation
Fair Value$12.96
Target Price$61.38
Upside/Downside2.13%
GradeFair
TypeBlend
Dividend Yield1.53%
Risk Assessment
Beta1.12
Volatility30.27%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.